News

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases

Fujifilm announces the Start of a New Phase III Clinical Trial of Anti-influenza Drug Avigan^® Tablet in Japan, Targeting COVID-19 Patients

Fujifilm applies for manufacturing and marketing approval for a SARS-CoV-2antigen test kit using silver amplification immunochromatography method

Fujifilm Partners with Chinese Pharmaceutical Company Carelink in Deploying Anti-influenza Drug Avigan^® Tablets in China

Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan^® Tablet in Japan to Include Additional Indication for COVID-19

Fujifilm Starts a Clinical Investigation in Europe on FF-37101, a Bone Grafting Material Useful for Bone Regeneration

A new magnetic recording method using millimeter/terahertz waves !!

Fujifilm to develop a highly-sensitive and rapid antigen test kit for SARS-CoV-2 utilizing silver halide amplification technology

Anti-influenza drug Avigan^® Tablet
Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients

To realize a new therapeutic option for neuroendocrine tumors
Domestic marketing approval application filed for new radiopharmaceutical F-1515 (FUJIFILM Toyama Chemical)

Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238, Biosimilar Bevacizumab

Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan

Fujifilm collaborates with Merck & Co., Inc., Kenilworth, N.J., U.S.A.  in a clinical trial for advanced solid tumor in combination therapy of FF-10832, a liposome drug candidate with KEYTRUDA^® (pembrolizumab)

Fujifilm to develop AI-based technology to aid COVID-19-induced pneumonia diagnosis and assess the effectiveness of treatments

FUJIFILM Toyama Chemical starts a Phase I Clinical Trial of
FF-21101 for the Treatment of Advanced Solid Tumors in Japan (FUJIFILM Toyama Chemical Co., Ltd.)

Fujifilm accelerates production of its influenza antiviral drug “Avigan^® Tablet” for COVID-19

Fujifilm announces the start of a phase II clinical trial of its influenza antiviral drug “Avigan^® Tablet” for COVID-19 patients in the U.S.  

Fujifilm announces the start of a phase III clinical trial of influenza antiviral drug “Avigan Tablet” on COVID-19 and commits to increasing production

Fujifilm Start Phase II Clinical Trial of T-817MA in Europe for Treatment of Alzheimer Disease

Fujifilm establishes the Bio Science & Engineering Laboratories U.S.A. to start full-scale translational research for biotherapeutics in the United States